Concurrent docetaxel and S-1 compared with oxaliplatin and s-1 as first-line therapy for advanced gastric adenocarcinoma: A retrospective study.

被引：0
|
作者：
Tan, Siyi
Xie, Jiaqi
Wei, Jia
Liu, Qin
Du, Juan
Liu, Baorui
Yang, Yang
机构：
[1] Nanjing Univ, Comprehens Canc Ctr, Drum Tower Hosp, Med Sch, Nanjing, Peoples R China
[2] Nanjing Univ, Clin Canc Inst, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16540
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study
    Wang, Mei
    Wu, Meihong
    Wang, Wei
    Wang, Qingshui
    Wang, Yajie
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (1-2) : 24 - 28
  • [2] S-1/docetaxel compared with the other standard S-1 based regimens as a first-line chemotherapy for patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Ando, Koji
    Ida, Satoshi
    Kimura, Yasue
    Saeki, Hiroshi
    Oki, Eiji
    Morita, Masaru
    Maehara, Yoshihiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
    Kazuaki Tanabe
    Takahisa Suzuki
    Noriaki Tokumoto
    Hideki Yamamoto
    Kazuhiro Yoshida
    Hideki Ohdan
    [J]. World Journal of Surgical Oncology, 8
  • [4] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
    Tanabe, Kazuaki
    Suzuki, Takahisa
    Tokumoto, Noriaki
    Yamamoto, Hideki
    Yoshida, Kazuhiro
    Ohdan, Hideki
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2010, 8
  • [5] Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer
    Tsutani, Yasuhiro
    Ohara, Masahiro
    Suzuki, Takahisa
    Minami, Kazuhito
    Miyahara, Eiji
    Kameda, Akira
    Noso, Yoshihiro
    [J]. ANTICANCER RESEARCH, 2009, 29 (07) : 2775 - 2779
  • [6] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [7] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    [J]. JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
  • [8] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: A retrospective analysis.
    Tanabe, K.
    Suzuki, T.
    Tokumoto, N.
    Yamamoto, H.
    Yoshida, K.
    Ohdan, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer
    Mo, Dun-Chang
    Qin, Lang
    Ye, Lin-Jing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (34) : 3883 - +
  • [10] A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer
    Yasushi Sato
    Tamotsu Sagawa
    Hiroyuki Ohnuma
    Masahiro Hirakawa
    Yasuo Takahashi
    Kyoko Hamaguchi
    Koshi Fujikawa
    Takayuki Nobuoka
    Koichi Okamoto
    Hiroshi Miyamoto
    Naoki Muguruma
    Ichiro Takemasa
    Tetsuji Takayama
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 161 - 167
12345